Feline Peritoneal Effusions—A Poor Prognosis?

Feline ascites has been reported to have a poor prognosis, with a median survival time of 21 days (considering all etiologies). However, previous studies included relatively small populations (<100 cases) and there is no literature evaluating the prognosis of all causes of feline ascites within the last 20 years. This study aimed to assess the survival times of a large population of cats presenting with ascites and assess the effect of the effusion cause, signalment, clinicopathological and imaging findings on survival. Data was acquired from the medical record system of a referral hospital (including both referrals and first-opinion emergency cases). Four hundred and ninety-eight cats met the inclusion criteria and 55% of all cases survived to discharge. Median survival time post-discharge was 30.5 days. The cause of the effusion was significantly associated with survival to discharge (<i>p</i> = 0.002). Common etiologies of ascites included neoplasia, septic peritonitis, sterile inflammatory disease, uroperitoneum, hemoperitoneum and cardiac disease. Uroperitoneum cases had the highest rate of survival to discharge (77%), while hemoperitoneum cases had the lowest percentage surviving to discharge (40%). Subjectively assessed effusion volume on imaging was significantly associated with survival to discharge (<i>p</i> = 0.012). Subjective assessment of the effusion volume and effusion assessment via abdominocentesis to help obtain a diagnosis can help guide prognosis and are diagnostics that do not require advanced techniques or specialist equipment, which can provide important prognostic information for cats presenting with ascites.

Authors

Institutions

Publication Details

Journal
Animals
Published
2025-11-20
DOI
https://doi.org/10.3390/ani15223355
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Feline Peritoneal Effusions—A Poor Prognosis?

Barbara Glanemann, Camilla Hindar, Sivert Nerhagen, Laura Letwin
Animals
Veterinary Oncology Research
article

Feline Peritoneal Effusions—A Poor Prognosis?

Barbara Glanemann, Camilla Hindar, Sivert Nerhagen, Laura Letwin
article en

Abstract

Feline ascites has been reported to have a poor prognosis, with a median survival time of 21 days (considering all etiologies). However, previous studies included relatively small populations (<100 cases) and there is no literature evaluating the prognosis of all causes of feline ascites within the last 20 years. This study aimed to assess the survival times of a large population of cats presenting with ascites and assess the effect of the effusion cause, signalment, clinicopathological and imaging findings on survival. Data was acquired from the medical record system of a referral hospital (including both referrals and first-opinion emergency cases). Four hundred and ninety-eight cats met the inclusion criteria and 55% of all cases survived to discharge. Median survival time post-discharge was 30.5 days. The cause of the effusion was significantly associated with survival to discharge (<i>p</i> = 0.002). Common etiologies of ascites included neoplasia, septic peritonitis, sterile inflammatory disease, uroperitoneum, hemoperitoneum and cardiac disease. Uroperitoneum cases had the highest rate of survival to discharge (77%), while hemoperitoneum cases had the lowest percentage surviving to discharge (40%). Subjectively assessed effusion volume on imaging was significantly associated with survival to discharge (<i>p</i> = 0.012). Subjective assessment of the effusion volume and effusion assessment via abdominocentesis to help obtain a diagnosis can help guide prognosis and are diagnostics that do not require advanced techniques or specialist equipment, which can provide important prognostic information for cats presenting with ascites.

AnimalsVol. 15(22)
Royal Veterinary College (GB), Whiteley Clinic (GB), Norwegian University of Life Sciences (NO)
Openalex Percentile: Top 49%
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.